Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by sah1on Aug 09, 2018 10:56am
213 Views
Post# 28433341

RE:RE:RE:RE:RE:RE:RE:RE:House position PLI today

RE:RE:RE:RE:RE:RE:RE:RE:House position PLI todayHard to see anyone offering even $3 a share at current sp but you never know. Such an offer could persuade retail and ultra longs to sell but not sure the billionaires would bite. $5 would definitely be more attractive.

I am hoping that there will be an equity component at premium to current share price of  a future 4050 deal. Also there will be an IPO when Pli lists on Nasdaq But hopefully that will be it in terms of future equity financing.
Bullboard Posts